Antibody-free, chemically mild, base-resolution mapping of transcriptome-wide m6A—designed for site-focused interpretation when you need more than peak-level enrichment.
CAM-seq is a chemically mild approach that converts adenine to hypoxanthine (read as G) while m6A resists deamination and remains A, enabling base-resolution detection logic without antibody enrichment.
m6A research has shifted from "is it present?" to "which exact sites change, and how does that connect to phenotype?" Yet many workflows still return region-level enrichment rather than site-level answers—making it hard to distinguish nearby events, prioritize follow-up targets, or explain mechanistic outcomes with confidence.
What this means for your study
CAM-seq infers m6A using an A-to-G readout: unmodified A is chemically deaminated to hypoxanthine/inosine (read as G), while m6A remains A.
CAM-seq is based on cooperative catalysis combining a carbonyl organocatalyst with a Lewis acid catalyst to enable selective deamination under mild conditions. In this workflow:
CAM-seq projects are typically designed for site discovery (build a base-resolution map) or comparative profiling (evaluate site-level differences across conditions).
Best for
Best for
Choose CAM-seq when your question requires site-level m6A interpretation, especially for mechanism studies, limited-input projects, or cross-species mapping.
CAM-seq is a good fit when your question needs site-level answers:
CAM-seq follows a poly(A)+ RNA workflow—enrichment → fragmentation → chemical conversion → library prep → sequencing → site reporting.
Below is a service-ready representation aligned to the published method logic (high-level, RUO):
CAM-seq bioinformatics converts sequencing data into site-focused outputs by performing QC, alignment, extracting A/G metrics, and generating annotated site tables and summary plots.
Bioinformatic Analysis Table (Standard vs. Advanced)
| Module | Standard (Included) | Advanced (Optional) |
|---|---|---|
| Data QC | Read quality summary; adapter/quality trimming summary; mapping rates | Sensitivity checks across QC thresholds; batch notes (if multi-batch) |
| Alignment | Reference alignment + core mapping statistics | Genome/transcriptome cross-checks (when relevant); expanded annotation layers |
| Site-oriented extraction | Site-level A/G outcome summaries and candidate site list | Artifact-focused filtering; configurable thresholds by sample type |
| Annotation & summaries | Transcript feature summaries; motif summaries; distribution plots | Condition overlays; motif stratification; targeted panels for manuscripts |
| Reporting | Structured report + tables for interpretation | Publication-format figure set and executive summary (RUO) |
CAM-seq is positioned around poly(A)+ RNA with fragmentation as part of the workflow; feasibility is driven primarily by RNA integrity, cleanliness, and achieving the target poly(A)+ input.
Sample Types & Submission Guidance
| Sample Type | Accepted Format | Submission Guidance |
|---|---|---|
| Extracted RNA | poly(A)+ RNA | 10 ng poly(A)+ RNA is reported as feasible starting input in provided summaries; practical requirements depend on study design and RNA quality. |
| Extracted RNA | Total RNA | Used as upstream material for poly(A) enrichment; amount depends on yield needs (project-specific). |
| Cells | Cell pellet | RNA-yield dependent; submit sufficient material to obtain the required poly(A)+ input. |
| Tissue | Fresh/frozen tissue | RNA-yield dependent; submit sufficient material to obtain the required poly(A)+ input. |
Important: CAM-seq outcomes depend on RNA quality and library construction. Fragmentation is part of the described workflow, and mild reaction conditions are intended to reduce degradation risk relative to harsher chemistries.
Deliverables are designed to be decision-ready, combining QC, site-focused tables, and summary plots that support interpretation and reporting.
What You'll Receive (Deliverables)




Use MeRIP-seq for region-level discovery, GLORI when absolute site-level quantification is the priority, and CAM-seq when you want an antibody-free, site-oriented readout positioned for mild chemistry and low-input feasibility.
| Dimension | MeRIP-seq | GLORI | CAM-seq |
|---|---|---|---|
| Core principle | Antibody IP enrichment + sequencing | Chemical A→I; m6A resists; A/(A+G) for quant | Cooperative-catalysis A→I; m6A resists; base-resolution site-oriented calling |
| Resolution | Regional (~100–200 nt) | Single-base | Single-base |
| Bias risk | Antibody specificity + IP bias | Chemistry/RT constraints | Antibody-free; mild chemistry emphasis |
| Input (as described) | Higher input typical | Higher input typical | Low-input poly(A)+ RNA positioning (e.g., 10 ng in provided summary) |
| Best fit | Transcriptome screening | Absolute quant focus | Low-input, low-background, site-focused profiling |
References
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.
Quote Request